Calorimetric and spectroscopic characterization of complexes between β-cyclodextrin or heptakis (2,6-di-O-methyl)-β-cyclodextrin and sertraline hydrochloride in aqueous solution

被引:13
|
作者
Belica, S. [1 ]
Jeziorska, D. [1 ]
Urbaniak, P. [2 ]
Buko, V. U. [3 ]
Zavodnik, I. B. [4 ]
Palecz, B. [1 ]
机构
[1] Univ Lodz, Dept Phys Chem, PL-90236 Lodz, Poland
[2] Univ Lodz, Dept Inorgan & Analyt Chem, PL-91403 Lodz, Poland
[3] Natl Acad Sci, Inst Biochem, Grodno 230030, BELARUS
[4] Yanka Kupala Grodno State Univ, Dept Biochem, Grodno 230017, BELARUS
来源
关键词
Sertraline hydrochloride; beta-Cyclodextrin; Heptakis(2,6-di-O-methyl)-beta-cyclodextrin; Isothermal titration calorimetry; H-1 NMR spectroscopy; UV-Vis absorption spectroscopy; Binding parameters; SUPRAMOLECULAR COMPLEX; INCLUSION COMPLEXES; PAMAM-NH2; G4; DRUGS; STABILITY; BINDING; ALPHA;
D O I
10.1016/j.jct.2013.10.035
中图分类号
O414.1 [热力学];
学科分类号
摘要
The interaction of sertraline hydrochloride (SRT) with beta-cyclodextrin (beta-CD) and heptakis(2,6-di-O-methyl)-beta-cyclodextrin (DM-beta-CD) in aqueous solutions was investigated using the methods of isothermal titration calorimetry (ITC), nuclear magnetic resonance (H-1 NMR) and UV-Vis spectroscopy. The interaction parameters, such as the association constant, enthalpy, entropy and Gibbs energy of complexation of SRT by beta-CD and DM-beta-CD in water at T = 298.15 K have been evaluated. Both enthalpic and entropic effects make a contribution to SRT association with beta-CD or DM-beta-CD. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:160 / 167
页数:8
相关论文
共 50 条
  • [1] Formation, characterization and pH dependence of rifampicin: heptakis( 2,6-di-O-methyl)-β-cyclodextrin complexes
    Angiolini, Lorenzo
    Agnes, Marco
    Cohen, Boiko
    Yannakopoulou, Konstantina
    Douhal, Abderrazzak
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 531 (02) : 668 - 675
  • [2] Inclusion phenomena of clove oil with α-, β-, γ- and heptakis (2,6-di-O-methyl)-β-cyclodextrin
    Song, L. X.
    Xu, P.
    Wang, H. M.
    Yang, Y.
    [J]. NATURAL PRODUCT RESEARCH, 2009, 23 (09) : 789 - 800
  • [3] HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN COMPLEXATION, WITH GLUTETHIMIDE
    ELGENDY, GA
    ELGENDY, MA
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (06) : 249 - 254
  • [4] The Interaction of Heptakis (2,6-di-O-Methyl)-β-cyclodextrin with Mianserin Hydrochloride and Its Influence on the Drug Toxicity
    Belica-Pacha, Sylwia
    Malecka, Magdalena
    Dasko, Mateusz
    Milowska, Katarzyna
    Bryszewska, Maria
    Budryn, Grazyna
    Oracz, Joanna
    Palecz, Bartlomiej
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [5] Encapsulation of 6-hydroxyquinoline in heptakis(2,6-di-O-methyl)-β-cyclodextrin
    Lee, Young-Shin
    Park, Han Jung
    Jang, Du-Jeon
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2006, 27 (09) : 1450 - 1452
  • [6] Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: Phase solubility and spectroscopic methods
    Shi, Jie-Hua
    Zhou, Ya-fang
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2011, 83 (01) : 570 - 574
  • [7] The Heptakis-(2,6-di-O-methyl)-β-cyclodextrin inclusion complex with acetic acid
    ER5128-CNRS, Centre Pharmaceutique, Université Paris-Sud, 92296 Chátenay-Malabry, France
    不详
    [J]. J. Incl. Phenom., 1 (1-12):
  • [8] The Heptakis-(2,6-di-O-methyl)-β-cyclodextrin Inclusion Complex with Acetic Acid
    M. Selkti
    A. Navaza
    F. Villain
    P. Charpin
    C. De Rango
    [J]. Journal of inclusion phenomena and molecular recognition in chemistry, 1997, 27 : 1 - 12
  • [9] PHYSICAL-PROPERTIES OF THE COMPLEXES FORMED BETWEEN HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN, BETA-CYCLODEXTRIN, AND CHLORAMBUCIL
    GREEN, AR
    MILLER, ES
    GUILLORY, JK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (02) : 186 - 189
  • [10] THE EFFECT OF HEPTAKIS (2,6-DI-O-METHYL)-GAMMA-CYCLODEXTRIN ON MITOMYCIN-C STABILITY IN AQUEOUS-SOLUTION
    SUENAGA, A
    BEKERS, O
    BEIJNEN, JH
    UNDERBERG, WJM
    TANIMOTO, T
    KOIZUMI, K
    OTAGIRI, M
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 59 (02) : 121 - 130